Patient-reported outcomes as a source of evidence in off-label prescribing: analysis of data from PatientsLikeMe.
BACKGROUND
Evaluating a new use for an existing drug can be expensive and time consuming. Providers and patients must all too often rely upon their own individual-level experience to inform clinical practice, which generates only anecdotal and unstructured data. While academic-led clinical trials are occasionally conducted to test off-label uses of drugs with expired patents, this is relatively rare. In this work, we explored how a patient-centered online research platform could supplement traditional trials to create a richer understanding of medical products postmarket by efficiently aggregating structured patient-reported data. PatientsLikeMe is a tool for patients, researchers, and caregivers (currently 82,000 members across 11 condition-based communities) that helps users make treatment decisions, manage symptoms, and improve outcomes. Members enter demographic information, longitudinal treatment, symptoms, outcome data, and treatment evaluations. These are reflected back as longitudinal health profiles and aggregated reports. Over the last 3 years, patients have entered treatment histories and evaluations on thousands of medical products. These data may aid in evaluating the effectiveness and safety of some treatments more efficiently and over a longer period of time course than is feasible through traditional trials.


OBJECTIVE
The objective of our study was to examine the illustrative cases of amitriptyline and modafinil - drugs commonly used off-label.


METHODS
We analyzed patient-reported treatment histories and drug evaluations for each drug, examining prevalence, treatment purpose, and evaluations of effectiveness, side effects, and burden.


RESULTS
There were 1948 treatment histories for modafinil and 1394 treatment reports for amitriptyline reported across five PatientsLikeMe communities (multiple sclerosis, Parkinson's disease, mood conditions, fibromyalgia/chronic fatigue syndrome, and amyotrophic lateral sclerosis). In these reports, the majority of members reported taking the drug for off-label uses. Only 34 of the 1755 (1%) reporting purpose used modafinil for an approved purpose (narcolepsy or sleep apnea). Only 104 out of 1197 members (9%) reported taking amitriptyline for its approved indication, depression. Members taking amitriptyline for off-label purposes rated the drug as more effective than those who were taking it for its approved indication. While dry mouth is a commonly reported side effect of amitriptyline for most patients, 88 of 220 (40%) of people with amyotrophic lateral sclerosis on the drug reported taking advantage of this side effect to treat their symptom of excess saliva.


CONCLUSIONS
Patient-reported outcomes, like those entered within PatientsLikeMe, offer a unique real-time approach to understand utilization and performance of treatments across many conditions. These patient-reported data can provide a new source of evidence about secondary uses and potentially identify targets for treatments to be studied systematically in traditional efficacy trials.
VU Amsterdam, KankerNL, Amsterdam, Netherlands. jeana.frost@gmail.com
Jeana
J
Frost
Sally
S
Okun
Timothy
T
Vaughan
James
J
Heywood
Paul
P
Wicks
D000639:Amitriptyline / Q000009:adverse effects / Q000627:therapeutic use; D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy / Q000378:metabolism; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D003072:Cognition Disorders / Q000188:drug therapy; D019058:Community Networks / Q000706:statistics & numerical data; D003659:Decision Making, Organizational; D005221:Fatigue / Q000188:drug therapy; D006801:Humans; D020407:Internet; D000077408:Modafinil; D056687:Off-Label Use; D018802:Patient-Centered Care / Q000458:organization & administration; D010361:Patients; D012463:Saliva / Q000187:drug effects / Q000378:metabolism; D057566:Self Report; D012894:Sleep Stages / Q000187:drug effects; D016896:Treatment Outcome
D001559:Benzhydryl Compounds; D000639:Amitriptyline; D000077408:Modafinil
J Med Internet Res. 2008 May 27;10(3):e15
18504244
Ann Pharmacother. 2010 Jun;44(6):1098-103
20442351
J Neurol Neurosurg Psychiatry. 2002 Feb;72(2):179-83
11796766
J Clin Rheumatol. 2007 Feb;13(1):52
17278955
Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Dec;4(4):258-63
14753660
N Engl J Med. 2008 Apr 3;358(14):1427-9
18385495
J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1636-9
16291885
Clin Neuropharmacol. 2002 Mar-Apr;25(2):111-4
11981239
N Engl J Med. 2009 Nov 12;361(20):1963-71
19907043
J Med Internet Res. 2010 Jun 14;12(2):e19
20542858
JAMA. 2008 Apr 23;299(16):1949-51
18430914
Pharmacotherapy. 2006 Mar;26(3):323-32
16503712
Arch Intern Med. 2006 May 8;166(9):1021-6
16682577
Mov Disord. 2003 Mar;18(3):287-93
12621632
CNS Drugs. 2007;21(4):279-91
17381183
N Engl J Med. 2009 Apr 9;360(15):1557-66
19357413
J Med Internet Res. 2005 Mar 16;7(1):e5
15829477
J Psychopharmacol. 2005 Nov;19(6):647-60
16272188
Hum Psychopharmacol. 2004 Jan;19(1):63-4
14716715
Asian J Psychiatr. 2009 Mar;2(1):29-36
23051015
Pharmacotherapy. 2008 Dec;28(12):1443-52
19025425